End-of-day quote
Other stock markets
|
||
- | - |
2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cosmetics Product
99.1
%
| 83,887 | 99.6 % | 96,272 | 99.1 % | +14.76% |
Cosmetics Merchandise
0.7
%
| 208 | 0.2 % | 677 | 0.7 % | +225.43% |
Other
0.2
%
| 118 | 0.1 % | 156 | 0.2 % | +32.23% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 84,212 | 100.0 % | 97,105 | 100.0 % | +15.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yang-Soo Kim
CEO | Chief Executive Officer | 54 | 01/12/01 |
Yoon Kim
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/00/01 |
Woo-Jae Lim
BRD | Director/Board Member | 45 | 25/21/25 |
Byeong-Cheol Im
PRN | Corporate Officer/Principal | 65 | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon Kim
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/00/01 |
Dong-Jin Choi
BRD | Director/Board Member | 64 | 21/19/21 |
Yang-Soo Kim
CEO | Chief Executive Officer | 54 | 01/12/01 |
Woo-Jae Lim
BRD | Director/Board Member | 45 | 25/21/25 |
Hak-Young Kim
BRD | Director/Board Member | 72 | 21/19/21 |
Gi-Young Hong
BRD | Director/Board Member | 68 | 21/19/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,207,361 | 4,674,864 ( 56.96 %) | 386,733 ( 4.712 %) | 56.96 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
NEOPHARM CO., LTD. 4.71% | 386,733 | 4.71% | 7,275,202 $ |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+0.32% | 262B | |
+18.76% | 20.37B | |
-.--% | 19.29B | |
+16.91% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-12.08% | 3.92B | |
-16.83% | 3.84B |
- Stock Market
- Equities
- A092730 Stock
- Stock
- Company NeoPharm Co., Ltd.